scholarly journals Cancer of unknown primary origin presented with rapid deterioration without significant symptoms, a case report

Author(s):  
Vahid Mansouri ◽  
Samaneh Toutounchian ◽  
Fatemeh Arabi ◽  
Farid Kosari ◽  
Sahar Tavakoli shiraji

A 34-year-old woman with flank pain was referred for suspicious lymphadenopathy. PET/CT scan revealed disseminated lesions without apparent primary origin. Although she did not complain of any symptoms, after rapid deterioration, she died of respiratory distress and cardiac arrest. Her strong beliefs contribute to symptoms tolerance and late diagnosis.

2020 ◽  
Author(s):  
Taketsugu Fujibuchi ◽  
Joji Miyawaki ◽  
Teruki Kidani ◽  
Hiroshi Imai ◽  
Hiromasa Miura

Abstract BackgroundThe occurrence of skeletal metastases of unknown primary origin (SMUP) is uncommon. To provide appropriate treatments for the primary and metastatic lesions, early diagnosis of the primary origin of SMUP is important. Therefore, this study aimed to assess the types of examination method effective in diagnosing the primary origin of SMUP and their order in terms of efficacy.MethodsWe retrospectively examined 63 patients with SMUP. The primary origin was examined via physical examination, blood test including tumor markers, chest radiography, thoracoabdominal computed tomography (CT) scan, positron emission tomography (PET)-CT scan, metastatic lesion biopsy, and other assessments. Examination methods considered effective for the diagnosis of the primary origin in a specific type of cancer were investigated.ResultsThe lung was the most common primary origin, followed by the lymph nodes, prostate, and breast. Meanwhile, biopsy (87.0%) was the most effective examination, followed by PET-CT scan (60.0%) and thoracoabdominal CT scan (38.6%). The first four steps; physical examination, blood tests, chest radiography, thoracoabdominal CT were effective in diagnosing the primary origin in 41 (65%) of 63 patients. Finally, four patients were diagnosed with SMUP.ConclusionsThe examination steps used in this study are effective in diagnosing the primary origin of SMUP during the initial visit. Blood tests are useful for hematological malignancy and prostate cancer. CT scan can be used to identify cancers in the lung, breast, and kidney, which are the common primary origins. Moreover, it is more useful than PET-CT scan from a comprehensive perspective.


2014 ◽  
Vol 105 (4) ◽  
pp. 212-217
Author(s):  
Masaki Haraoka ◽  
Mariko Takamuki ◽  
Youichiro Toyonaga ◽  
Michio Tanaka ◽  
Kisaburo Hanazawa ◽  
...  

2009 ◽  
Vol 56 (4) ◽  
pp. 159-164
Author(s):  
S.M. Lucic ◽  
M.A. Lucic ◽  
A. Peter ◽  
D. Jovanovic ◽  
V. Vucaj-Cirilovic

Cancer of unknown primary origin is not an uncommon clinical state, usually accounting for 2%-7% of all cancer patients. Material and methods: Positron emission tomography and computed tomography (PET/CT) was performed in 17 patients with histologically proven metastatic tumors of unknown primary and negative or inconclusive conventional diagnostic procedures. Results: The study included 17 patients (8 male and 9 female) age from 42 to 76 years. PET / CT has pointed out the probable localization of primary tumors in 10 patients. According histological diagnosis of carcinoma of unknown origin, most common is adenocarcinoma (64.71%). Origin of the primary cancer was found in 72.73% patients with adenocarcinoma 66.67% of respondents with squamocelular carcinoma and 50% of respondents with low differentiated carcinoma. Location of primary cancer was not found in 41.18% of the respondents, including patients with mucinous adenocarcinoma and patients with melanoma. Conclusion: FDG PET/CT demonstrates very good whole-body imaging method in evaluation of patients with unknown primary carcinoma.


2021 ◽  
Vol 11 ◽  
Author(s):  
Murilo Bonatelli ◽  
Isabella Fernandes Fornari ◽  
Priscila Neves Bernécule ◽  
Lara Esquiapatti Pinheiro ◽  
Ricardo Filipe Alves Costa ◽  
...  

IntroductionCancer of unknown primary origin (CUP) is defined as metastatic cancer without identification of the primary site. Considering that only 15–20% of patients with CUP show a favorable outcome, identifying biomarkers may help improve the clinical management of patients who do not respond well to conventional therapies. In this context, the study of the metabolic profile of CUP may pave the way to establish new biomarkers and/or therapeutic targets; therefore, this study aimed to characterize the expression of metabolism-related proteins in CUP.Materials and MethodsThe expression of monocarboxylate transporters MCT1, MCT2 and MCT4, their chaperone CD147, the glucose transporter GLUT1 and the pH regulator CAIX was evaluated by immunohistochemistry in a series of 118 CUP patients, and the results were associated with the available clinicopathological information.ResultsThe metabolism-related proteins MCT1, MCT4, CD147, GLUT1 and CAIX were expressed in a critical portion of the CUP (approximately 20 to 70%). MCT1 and CD147 were both more frequently expressed in cases with lymph nodes as metastasis dominant sites (p = 0.001) as well as in samples from lymph nodes (p <0.001 and p = 0.002, respectively), while MCT1 expression was more frequently expressed in squamous cell carcinomas (p = 0.045). A higher overall survival was observed in patients with tumors positive for GLUT1 and CAIX expression (p = 0.011 and p = 0.041, respectively), but none of the proteins was an independent prognostic factor for overall survival in multivariable analysis.ConclusionThe results suggest that a portion of CUPs present a hyperglycolytic phenotype, which is associated with higher overall survival.


2015 ◽  
Vol 10 (4) ◽  
pp. 2657-2661
Author(s):  
ANA CEBOLLERO DE MIGUEL ◽  
ROBERTO PAZO CID ◽  
JAVIER MARTINEZ TRUFERO ◽  
ISABEL PAJARES BERNAD ◽  
LOURDES CALERA URQUIZU ◽  
...  

1997 ◽  
Vol 2 (3) ◽  
pp. 142-152 ◽  
Author(s):  
Evangelos Briasoulis ◽  
Nicholas Pavlidis

Sign in / Sign up

Export Citation Format

Share Document